A PHASE III SINGLE-ARM STUDY OF A NEW 13.5 MG LEVONORGESTREL INTRAUTERINE CONTRACEPTIVE SYSTEM IN POSTMENARCHEAL ADOLESCENTS: AN EVALUATION OF EFFICACY, BLEEDING, USER SATISFACTION, AND PLACEMENT.

被引：2

作者：

Gemzell-Danielsson, K. ^{[1
]}

Dermout, S. ^{[2
]}

Lukkari-Lax, E. ^{[3
]}

Montegriffo, E. ^{[4
]}

Rybowski, S. ^{[5
]}

Apter, D. ^{[6
]}

机构：

[1] Karolinska Inst, Stockholm, Sweden

[2] Gynaecol Ctr Dermout & Albicher, Alkmaar, Netherlands

[3] Bayer Oy, Espoo, Finland

[4] Bayer HealthCare, Newbury, Berks, England

[5] Bayer HealthCare, Whippany, NJ USA

[6] Sexual Hlth Clin, Vaestoliitto, Finland

来源：

关键词：

D O I：

10.1016/j.fertnstert.2014.07.484

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

P-3

引用

页码：E141 / E142

页数：2